Trial Profile
Study of the Effect of Chondroitin Sulfate(CONDROSAN) on Structural Changes in Knee Osteoarthritis Patients Assessed by MRI
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Chondroitin sulfate (Primary) ; Celecoxib
- Indications Osteoarthritis
- Focus Registrational; Therapeutic Use
- Acronyms MOSAIC
- Sponsors Bioiberica
- 14 Jun 2017 According to a Bioiberica media release, results from this and the CONCEPT trial will be presented at the 2017 Annual European Congress of Rheumatology.
- 09 Jan 2017 Primary endpoint (Cartilage Volume Loss of the Lateral Compartment) has been met, according to a Bioiberica media release.
- 09 Jan 2017 According to a Bioiberica media release, results from the study were published in the Arthritis Research and Therapy journal.